当前位置:首页 - 行情中心 - 奥精医疗(688613) - 财务分析 - 现金流量表

奥精医疗

(688613)

  

流通市值:27.58亿  总市值:27.58亿
流通股本:1.37亿   总股本:1.37亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金189,844,695.76134,873,470.3150,030,308.14192,459,428.79
  收到的税费返还919,556.99259,848.141,116,283.3-
  收到其他与经营活动有关的现金8,890,227.278,669,590.93352,932.454,933,282.7
  经营活动现金流入的平衡项目000.010
  经营活动现金流入小计199,654,480.02143,802,909.3851,499,523.9197,392,711.49
  购买商品、接受劳务支付的现金73,123,632.9461,919,364.8821,491,380.5372,852,609.36
  支付给职工以及为职工支付的现金63,908,717.845,457,485.3627,899,464.666,608,599.56
  支付的各项税费23,077,450.9216,840,756.685,135,776.4822,925,267.68
  支付其他与经营活动有关的现金44,041,770.8923,823,460.6812,304,322.454,609,522.79
  经营活动现金流出小计204,151,572.55148,041,067.666,830,944.01216,995,999.39
  经营活动产生的现金流量净额-4,497,092.53-4,238,158.22-15,331,420.11-19,603,287.9
二、投资活动产生的现金流量:
  收回投资收到的现金25,000,00013,000,0003,000,000938,553,000
  取得投资收益收到的现金39,774.4815,855.88,999.155,890,067.89
  处置固定资产、无形资产和其他长期资产收回的现金净额2271521122,551
  投资活动现金流入小计25,040,001.4813,016,007.83,009,111.1994,445,618.89
  购建固定资产、无形资产和其他长期资产支付的现金17,968,305.548,552,469.961,241,697.9213,426,340.44
  投资支付的现金30,000,00020,000,0005,000,000942,180,000
  取得子公司及其他营业单位支付的现金---24,619,207.31
  投资活动现金流出小计47,968,305.5428,552,469.966,241,697.92980,225,547.75
  投资活动产生的现金流量净额-22,928,304.06-15,536,462.16-3,232,586.8214,220,071.14
三、筹资活动产生的现金流量:
  吸收投资收到的现金14,705,486.4314,705,486.43-22,521,892.25
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计14,705,486.4314,705,486.43-22,521,892.25
  偿还债务支付的现金3,692,173.332,300,0001,300,00010,021,916.73
  分配股利、利润或偿付利息支付的现金1,745,187.621,181,869.43603,845.8910,778,758.52
  支付其他与筹资活动有关的现金1,023,898.281,023,898.28-670,835.87
  筹资活动现金流出小计6,461,259.234,505,767.711,903,845.8921,471,511.12
  筹资活动产生的现金流量净额8,244,227.210,199,718.72-1,903,845.891,050,381.13
四、汇率变动对现金及现金等价物的影响409,595.3280,778.77186,943.7-204,631.75
五、现金及现金等价物净增加额-18,771,574.09-9,294,122.89-20,280,909.12-4,537,467.38
  加:期初现金及现金等价物余额156,714,432.71156,714,432.71156,714,432.71161,251,900.09
  期末现金及现金等价物余额137,942,858.62147,420,309.82136,433,523.59156,714,432.71
补充资料:
  净利润-5,536,353.97--17,139,031
  资产减值准备----201,283.84
  固定资产和投资性房地产折旧-7,813,777.36-15,277,977.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,813,777.36-15,277,977.54
  无形资产摊销-1,012,669.3-1,739,300.78
  长期待摊费用摊销-4,166,629.93-6,462,054.28
  处置固定资产、无形资产和其他长期资产的损失--170,568.35--637,448.22
  公允价值变动损失--6,907,221.52--6,350,717.03
  财务费用-1,230,683.18-3,079,515
  投资损失--15,855.8--11,564,831.6
  递延所得税-0--3,120,097.51
  其中:递延所得税资产减少---2,410,694.12
    递延所得税负债增加----5,530,791.63
  存货的减少--41,892,368.95--22,353,614.21
  经营性应收项目的减少-18,705,686.12--21,153,868.11
  经营性应付项目的增加-9,064,095.85-25,787,088.58
  现金的期末余额-147,420,309.82-156,714,432.71
  减:现金的期初余额-156,714,432.71-161,251,900.09
  现金及现金等价物的净增加额--9,294,122.89--4,537,467.38
公告日期2025-10-302025-08-302025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑